1. Academic Validation
  2. FETPY: a Diiron(I) Thio-Carbyne Complex with Prominent Anticancer Activity In Vitro and In Vivo

FETPY: a Diiron(I) Thio-Carbyne Complex with Prominent Anticancer Activity In Vitro and In Vivo

  • J Med Chem. 2024 May 9;67(9):7553-7568. doi: 10.1021/acs.jmedchem.4c00377.
Ekatarina Mihajlović 1 Lorenzo Biancalana 2 Sanja Jelača 1 Lorenzo Chiaverini 2 Biljana Dojčinović 3 Duško Dunđerović 4 Stefano Zacchini 5 Sanja Mijatović 1 Danijela Maksimović-Ivanić 1 Fabio Marchetti 2
Affiliations

Affiliations

  • 1 Department of Immunology, Institute for Biological Research "Siniša Stanković" - National Institute of the Republic of Serbia, University of Belgrade, Belgrade 11108, Serbia.
  • 2 Department of Chemistry and Industrial Chemistry, University of Pisa, Via Giuseppe Moruzzi 13, Pisa I-56124, Italy.
  • 3 Institute of Chemistry, Technology and Metallurgy University of Belgrade, Njegoševa 12, Belgrade 11000, Serbia.
  • 4 Institute of Pathology, School of Medicine University of Belgrade, dr Subotića 1, Belgrade 11000, Serbia.
  • 5 Department of Industrial Chemistry "Toso Montanari", University of Bologna, Via P. Gobetti 85, Bologna I-40129, Italy.
Abstract

FETPY, an organo-diiron(I) complex, showed strong cytotoxicity across a panel of human and mouse Cancer cell lines, combined with an outstanding selectivity compared to nonmalignant cells. Enhanced iron uptake in aggressive, low-differentiated cell lines, caused membrane lipid peroxidation, which resulted in Ferroptosis in human ovarian Cancer cells. FETPY induced significant morphological changes in murine B16-F1 and B16-F10 melanoma cells, leading to senescence and/or trans-differentiation into Schwann-like cells, thus significantly reducing their tumorigenic potential. Additionally, FETPY substantially suppressed tumor growth in low- and high-grade syngeneic melanoma models when administered in a therapeutic regimen. FETPY is featured by satisfactory water solubility (millimolar range), an amphiphilic character (Log Pow = -0.17), and excellent stability in a biological medium (DMEM). These important requisites for drug development are rarely met in iron complexes investigated so far as possible Anticancer agents. Overall, FETPY holds promise as a safe and potent targeted antitumor agent.

Figures
Products